Meta-Analysis
. 2022 Sep 1;8(9):1287-1293. doi: 10.1001/jamaoncol.2022.2617. Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysisAffiliations
AffiliationsItem in Clipboard
Meta-Analysis
Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysisFederica Teglia et al. JAMA Oncol. 2022.
. 2022 Sep 1;8(9):1287-1293. doi: 10.1001/jamaoncol.2022.2617. AffiliationsItem in Clipboard
AbstractImportance: Public health services, including cancer screening tests, have been affected by the onset of the COVID-19 epidemic.
Objective: To investigate the pandemic's association with cancer screening worldwide.
Data sources: In this systematic review and meta-analysis, databases such as PubMed, ProQuest, and Scopus were searched comprehensively for articles published between January 1, 2020, and December 12, 2021.
Study selection: Observational studies and articles that reported data from cancer registries that compared the number of screening tests performed before and during the pandemic for breast, cervical, and colorectal cancer were included.
Data extraction and synthesis: Two pairs of independent reviewers extracted data from the selected studies. The weighted average of the percentage variation was calculated between the 2 periods to assess the change in the number of cancer screening tests performed during the pandemic. Stratified analysis was performed by geographic area, period, and type of setting. The systematic review and meta-analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline.
Main outcomes and measures: The main outcome was the weighted average percentage variation in the number of screening tests performed between January and October 2020 compared with the previous period.
Results: The review comprised 39 publications. There was an overall decrease of -46.7% (95% CI, -55.5% to -37.8%) for breast cancer screening, -44.9% (95% CI, -53.8% to -36.1%) for colorectal cancer screening, and -51.8% (95% CI, -64.7% to -38.9%) for cervical cancer screening during the pandemic. For all 3 cancers, a U-shaped temporal trend was identified; for colorectal cancer, a significant decrease was still apparent after May 2020 (in June to October, the decrease was -23.4% [95% CI, -44.4% to -2.4%]). Differences by geographic area and screening setting were also identified.
Conclusions and relevance: A summary estimate of the downscaling of cancer screening tests since the onset of the COVID-19 pandemic is provided in this systematic review and meta-analysis. This could be associated with an increase in the number of avoidable cancer deaths. Effective interventions are required to restore the capacity of screening services to the prepandemic level.
Conflict of interest statementConflict of Interest Disclosures: None reported.
FiguresFigure 1.. PRISMA (Preferred Reporting Items for…
Figure 1.. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) Flow Diagram of Information…
Figure 1.. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) Flow Diagram of Information Through the Various Phases of the Systematic ReviewFigure 2.. Weighted Average Variation of Screening…
Figure 2.. Weighted Average Variation of Screening Tests Performed From January to October 2020 Compared…
Figure 2.. Weighted Average Variation of Screening Tests Performed From January to October 2020 Compared With the Prepandemic Period, by Cancer Type and Period Similar articlesAngelini M, Teglia F, Astolfi L, Casolari G, Boffetta P. Angelini M, et al. Eur J Epidemiol. 2023 Jan;38(1):31-38. doi: 10.1007/s10654-022-00946-6. Epub 2023 Jan 3. Eur J Epidemiol. 2023. PMID: 36593334 Free PMC article. Review.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Teglia F, Angelini M, Casolari G, Astolfi L, Boffetta P. Teglia F, et al. Cancers (Basel). 2022 Nov 8;14(22):5490. doi: 10.3390/cancers14225490. Cancers (Basel). 2022. PMID: 36428583 Free PMC article.
Lofters AK, Wu F, Frymire E, Kiran T, Vahabi M, Green ME, Glazier RH. Lofters AK, et al. JAMA Netw Open. 2023 Nov 1;6(11):e2343796. doi: 10.1001/jamanetworkopen.2023.43796. JAMA Netw Open. 2023. PMID: 37983033 Free PMC article.
Mazidimoradi A, Tiznobaik A, Salehiniya H. Mazidimoradi A, et al. J Gastrointest Cancer. 2022 Sep;53(3):730-744. doi: 10.1007/s12029-021-00679-x. Epub 2021 Aug 18. J Gastrointest Cancer. 2022. PMID: 34406626 Free PMC article. Review.
Seishima R, Tachimori H, Fukuda K, Ikeda N, Miyata H, Fushimi K, Kitagawa Y. Seishima R, et al. BMJ Open. 2024 Dec 26;14(12):e084630. doi: 10.1136/bmjopen-2024-084630. BMJ Open. 2024. PMID: 39725419 Free PMC article.
Wang Q, Wu R, Wang J, Li Y, Xiong Q, Xie F, Feng P. Wang Q, et al. Front Oncol. 2023 Jul 17;13:1163333. doi: 10.3389/fonc.2023.1163333. eCollection 2023. Front Oncol. 2023. PMID: 37529694 Free PMC article.
Wang Y, Chang L, He H, Zhang X, Liu J, Zang L, Li L, Liu T, Xu Q. Wang Y, et al. Discov Oncol. 2025 Apr 17;16(1):545. doi: 10.1007/s12672-025-02205-y. Discov Oncol. 2025. PMID: 40244485 Free PMC article.
Ogawa S, Endo H, Yoshida M, Tsuru T, Itabashi M, Yamamoto H, Kakeji Y, Ueno H, Kitagawa Y, Hibi T, Taketomi A, Ikeda N, Mori M. Ogawa S, et al. Ann Gastroenterol Surg. 2024 Apr 15;8(5):795-806. doi: 10.1002/ags3.12806. eCollection 2024 Sep. Ann Gastroenterol Surg. 2024. PMID: 39229559 Free PMC article.
Klamminger GG, Bitterlich A, Nigdelis MP, Schnöder L, Hamoud BH, Solomayer EF, Wagner M. Klamminger GG, et al. J Clin Med. 2024 Jul 11;13(14):4058. doi: 10.3390/jcm13144058. J Clin Med. 2024. PMID: 39064099 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3